Across TCGA pan-cancer cohorts, OR7E23P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR7E23P’s most consistent transcriptional readouts.
The strongest signal is observed in esophageal carcinoma (ESCA), where OR7E23P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E23P is over-expressed in tumor.
ESCA are the cancer types where OR7E23P tumor–normal differential expression is most reproducible.